Monaco Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Monaco Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.9M	Sell	2,231,026 -1,189,994	-35%	-$5.14M	1.11%	17
2026 Q1	$9.68M	Sell	3,421,020 -39,170	-1%	-$133K	1.79%	18
2025 Q4	$11.2M	Sell	3,460,190 -196,147	-5%	-$660K	1.95%	14
2025 Q3	$10.5M	Buy	3,656,337 +2,775,372	+315%	+$7.09M	0.64%	16
2025 Q2	$2.12M	Buy	880,965 +45,100	+5%	+$94.8K	0.37%	44
2025 Q1	$1.85M	Buy	835,865 +544,501	+187%	+$2.15M	0.38%	35
2024 Q4	$1.59M	Buy	291,364 +216,364	+288%	+$1.39M	0.23%	48
2024 Q3	$623K	Sell	75,000 -125,000	-63%	-$1.08M	0.09%	62
2024 Q2	$1.43M	Buy	200,000 +41,849	+26%	+$361K	0.23%	38
2024 Q1	$1.37M	Sell	158,151 -153,059	-49%	-$1.04M	0.41%	38
2023 Q4	$2.04M	Buy	+311,210	New	+$2.01M	0.6%	41

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Monaco Asset Management's MRVI Position: Q2 2026 in Review

Monaco Asset Management reduced its Maravai LifeSciences (MRVI) stake by 35% in Q2 2026, selling an estimated $5.14M and leaving 2,231,026 shares worth $13.9M. The position accounts for 1.11% of the portfolio, ranked #17.

Monaco Asset Management first reported a position in MRVI in Q4 2023 and has held it in 11 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Monaco Asset Management held 2,231,026 shares of Maravai LifeSciences worth $13.9M as of Q2 2026.
Monaco Asset Management sold 1,189,994 Maravai LifeSciences shares in Q2 2026, an estimated $5.14M.
Maravai LifeSciences made up 1.11% of Monaco Asset Management's portfolio in Q2 2026, its #17 holding.
Monaco Asset Management first reported a position in Maravai LifeSciences in Q4 2023 and has held it in 11 quarters since.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.